The antitumor activity of the extract from human urine

Chinese Pharmacological Bulletin

Volumn 20, Issue 1, 2004, Pages 69-71

  Ma, Ya Feng ^a   Chen, Jun Hui ^a   Zhang, Dong Mei ^a   Wang, Xin Chang ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Acute toxicity; Antitumor activity; Extract from human urine

Indexed keywords

PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; URIC ANTITUMOR PEPTIDE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LD 50; LEUKOCYTE; LIVER CELL CARCINOMA; LUNG CARCINOMA; MOUSE; NONHUMAN; SARCOMA; TUMOR CELL; URINE;

EID: 1842523056     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Burzynsky R. Isolation, purification and synthesis of antineoplastons. International Journal of Experimental and Clinical Chemotherapy, 1989; 2: 63-9
2. 10 (NSC648539) and AS2-1 (NSC620261) in patients with recurrent glioma. Mayo Clin Proc, 1999; 74(2): 137-45
3. Badria F, Mabed M, Khafagy W et al. Potential utility of antineoplaston A-10 levels in breast cancer. Cancer Letter, 2000; 155 (1): 67-70
4. Badria F, Mabed M, El-Awadi M et al. Immune modulatory potentials of antineoplaston A-10 in breast cancer patients. Cancer Lett, 2000; 157(1): 57-63